These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8481226)
1. Wide third ventricle correlates with low choline acetyltransferase activity of the neocortex in Alzheimer patients. Soininen H; Reinikainen KJ; Puranen M; Helkala EL; Paljärvi L; Riekkinen PJ Alzheimer Dis Assoc Disord; 1993; 7(1):39-47. PubMed ID: 8481226 [TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism. Slansky I; Herholz K; Pietrzyk U; Kessler J; Grond M; Mielke R; Heiss WD Neuroradiology; 1995 May; 37(4):270-7. PubMed ID: 7666958 [TBL] [Abstract][Full Text] [Related]
3. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Bondareff W; Mountjoy CQ; Roth M; Rossor MN; Iversen LL; Reynolds GP; Hauser DL Alzheimer Dis Assoc Disord; 1987; 1(4):256-62. PubMed ID: 3453748 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370 [TBL] [Abstract][Full Text] [Related]
5. Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease. Soininen H; Reinikainen KJ; Partanen J; Helkala EL; Paljärvi L; Riekkinen PJ Neuroscience; 1992 Aug; 49(3):529-35. PubMed ID: 1501764 [TBL] [Abstract][Full Text] [Related]
6. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia. Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK J Neural Transm; 1988; 73(2):121-8. PubMed ID: 3210004 [TBL] [Abstract][Full Text] [Related]
7. Cholinergic markers in elderly patients with early signs of Alzheimer disease. Davis KL; Mohs RC; Marin D; Purohit DP; Perl DP; Lantz M; Austin G; Haroutunian V JAMA; 1999 Apr; 281(15):1401-6. PubMed ID: 10217056 [TBL] [Abstract][Full Text] [Related]
8. A post-mortem study of the cholinergic and GABA systems in senile dementia. Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. Wilcock GK; Esiri MM; Bowen DM; Smith CC J Neurol Sci; 1982 Dec; 57(2-3):407-17. PubMed ID: 7161627 [TBL] [Abstract][Full Text] [Related]
10. Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease. Moossy J; Zubenko GS; Martinez AJ; Rao GR; Kopp U; Hanin I Arch Neurol; 1989 Jun; 46(6):639-42. PubMed ID: 2730376 [TBL] [Abstract][Full Text] [Related]
11. A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease. Zubenko GS; Moossy J; Martinez AJ; Rao GR; Kopp U; Hanin I Arch Neurol; 1989 Jun; 46(6):634-8. PubMed ID: 2730375 [TBL] [Abstract][Full Text] [Related]
12. Cortical and central atrophy in chronic schizophrenia. A controlled study. Okasha A; Madkour O Acta Psychiatr Scand; 1982 Jan; 65(1):29-34. PubMed ID: 7187173 [TBL] [Abstract][Full Text] [Related]
13. Primary progressive aphasia, left anterior atrophy, and neurofibrillary hippocampal pathology: observations in an unusual case. Engel PA; Fleming PD Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):213-8. PubMed ID: 9297716 [TBL] [Abstract][Full Text] [Related]
14. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. Esiri MM; Pearson RC; Steele JE; Bowen DM; Powell TP J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):161-5. PubMed ID: 2313304 [TBL] [Abstract][Full Text] [Related]
15. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843 [TBL] [Abstract][Full Text] [Related]
16. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Tiraboschi P; Hansen LA; Alford M; Merdes A; Masliah E; Thal LJ; Corey-Bloom J Arch Gen Psychiatry; 2002 Oct; 59(10):946-51. PubMed ID: 12365882 [TBL] [Abstract][Full Text] [Related]
17. Computerised tomography in Alzheimer's disease. Methods of scan analysis, comparison with normal controls, and clinical/radiological associations. Burns A; Jacoby R; Philpot M; Levy R Br J Psychiatry; 1991 Nov; 159():609-14. PubMed ID: 1756335 [TBL] [Abstract][Full Text] [Related]
18. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Perry EK; Marshall E; Perry RH; Irving D; Smith CJ; Blessed G; Fairbairn AF Alzheimer Dis Assoc Disord; 1990; 4(2):87-95. PubMed ID: 2357341 [TBL] [Abstract][Full Text] [Related]